Literature DB >> 17710374

Chemotherapy as first line treatment for oligodendroglioma.

Athanassios P Kyritsis, Vinay K Puduvalli, Victor A Levin.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17710374     DOI： 10.1007/s11060-007-9465-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  4 in total

1.  Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

Authors:  Gregory Cairncross; Brian Berkey; Edward Shaw; Robert Jenkins; Bernd Scheithauer; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperierre; Minesh Mehta; Walter Curran
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

2.  Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.

Authors:  Vinay K Puduvalli; Masood Hashmi; Leslie D McAllister; Victor A Levin; Kenneth R Hess; Michael Prados; Kurt A Jaeckle; W K Alfred Yung; Saundra S Buys; Janet M Bruner; Jeannette J Townsend; Richard Davis; Raymond Sawaya; Athanassios P Kyritsis
Journal:  Oncology       Date:  2003       Impact factor: 2.935

3.  The treatment of anaplastic oligodendrogliomas and mixed gliomas.

Authors:  A P Kyritsis; W K Yung; J Bruner; M J Gleason; V A Levin
Journal:  Neurosurgery       Date:  1993-03       Impact factor: 4.654

4.  Role of exclusive chemotherapy as first line treatment in oligodendroglioma.

Authors:  Marie Pierre Sunyach; Anne Jouvet; David Perol; Emmanuel Jouanneau; Jacques Guyotat; Laurence Gignoux; Christian Carrie; Didier Frappaz
Journal:  J Neurooncol       Date:  2007-06-14       Impact factor: 4.130
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.